Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Interim Analysis Data from Multi-Center Retrospective Observational Study of Effectiveness, Safety, and Treatment Status of Tirabrutinib in 161 Japanese Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma: Rosetta Study

Blood (2024) 144 (Supplement 1): 572.

https://doi.org/10.1182/blood-2024-198558

Published: 2024

Journal Articles

Elevated Serum Soluble Interleukin-2 Receptor Level Is a Useful Prognostic Factor for Disease-Specific Overall Survival in Patients with Newly Diagnosed Follicular Lymphoma before Initiation of Treatment

Blood (2019) 134 (Supplement_1): 3985.

https://doi.org/10.1182/blood-2019-126399

Published: 2019

Journal Articles

Short Cycle of Immunochemotherapy Followed by Radiation Therapy Compared with Prolonged Cycles of Immunochemotherapy for Localized DLBCL: The Osaka Lymphoma Study Group (OLSG) Retrospective Analysis

Blood (2012) 120 (21): 1628.

https://doi.org/10.1182/blood.V120.21.1628.1628

Published: 2012

Journal Articles

Necessity of tyrosine 719 and phosphatidylinositol 3′-kinase–mediated signal pathway in constitutive activation and oncogenic potential of c- kit receptor tyrosine kinase with the Asp814Val mutation

Koji Hashimoto, Itaru Matsumura, Tohru Tsujimura, Dae-Ki Kim, Hideki Ogihara, Hirokazu Ikeda, Shuji Ueda, Masao Mizuki, Hiroyuki Sugahara, Hirohiko Shibayama, Yukihiko Kitamura, Yuzuru Kanakura

Blood (2003) 101 (3): 1094–1102.

https://doi.org/10.1182/blood-2002-01-0177

Published: 2003

Journal Articles

Critical roles of c-Kit tyrosine residues 567 and 719 in stem cell factor–induced chemotaxis: contribution of src family kinase and PI3-kinase on calcium mobilization and cell migration

Shuji Ueda, Masao Mizuki, Hirokazu Ikeda, Tohru Tsujimura, Itaru Matsumura, Kazushi Nakano, Hanako Daino, Zen-ichiro Honda, Junko Sonoyama, Hirohiko Shibayama, Hiroyuki Sugahara, Takashi Machii, Yuzuru Kanakura

Blood (2002) 99 (9): 3342–3349.

https://doi.org/10.1182/blood.V99.9.3342

Published: 2002

Journal Articles

Activating Mutation in the Catalytic Domain of c- kit Elicits Hematopoietic Transformation by Receptor Self-Association Not at the Ligand-Induced Dimerization Site

Tohru Tsujimura, Koji Hashimoto, Hitoshi Kitayama, Hirokazu Ikeda, Hiroyuki Sugahara, Itaru Matsumura, Tsuneyasu Kaisho, Nobuyuki Terada, Yukihiko Kitamura, Yuzuru Kanakura

Blood (1999) 93 (4): 1319–1329.

https://doi.org/10.1182/blood.V93.4.1319

Published: 1999

Journal Articles

Growth-Supporting Activities of Fibronectin on Hematopoietic Stem/Progenitor Cells In Vitro and In Vivo: Structural Requirement for Fibronectin Activities of CS1 and Cell-Binding Domains

Takafumi Yokota, Kenji Oritani, Hideki Mitsui, Keisuke Aoyama, Jun Ishikawa, Hiroyuki Sugahara, Itaru Matsumura, Schickwann Tsai, Yoshiaki Tomiyama, Yuzuru Kanakura, Yuji Matsuzawa

Blood (1998) 91 (9): 3263–3272.

https://doi.org/10.1182/blood.V91.9.3263

Published: 1998

NARROW

Interim Analysis Data from Multi-Center Retrospective Observational Study of Effectiveness, Safety, and Treatment Status of Tirabrutinib in 161 Japanese Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma: Rosetta Study

Elevated Serum Soluble Interleukin-2 Receptor Level Is a Useful Prognostic Factor for Disease-Specific Overall Survival in Patients with Newly Diagnosed Follicular Lymphoma before Initiation of Treatment

Short Cycle of Immunochemotherapy Followed by Radiation Therapy Compared with Prolonged Cycles of Immunochemotherapy for Localized DLBCL: The Osaka Lymphoma Study Group (OLSG) Retrospective Analysis

Necessity of tyrosine 719 and phosphatidylinositol 3′-kinase–mediated signal pathway in constitutive activation and oncogenic potential of c- kit receptor tyrosine kinase with the Asp814Val mutation

Critical roles of c-Kit tyrosine residues 567 and 719 in stem cell factor–induced chemotaxis: contribution of src family kinase and PI3-kinase on calcium mobilization and cell migration

Activating Mutation in the Catalytic Domain of c- kit Elicits Hematopoietic Transformation by Receptor Self-Association Not at the Ligand-Induced Dimerization Site

Growth-Supporting Activities of Fibronectin on Hematopoietic Stem/Progenitor Cells In Vitro and In Vivo: Structural Requirement for Fibronectin Activities of CS1 and Cell-Binding Domains

Email alerts

ASH Publications

American Society of Hematology

Interim Analysis Data from Multi-Center Retrospective Observational Study of Effectiveness, Safety, and Treatment Status of Tirabrutinib in 161 Japanese Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma: Rosetta Study

Elevated Serum Soluble Interleukin-2 Receptor Level Is a Useful Prognostic Factor for Disease-Specific Overall Survival in Patients with Newly Diagnosed Follicular Lymphoma before Initiation of Treatment

Short Cycle of Immunochemotherapy Followed by Radiation Therapy Compared with Prolonged Cycles of Immunochemotherapy for Localized DLBCL: The Osaka Lymphoma Study Group (OLSG) Retrospective Analysis

Necessity of tyrosine 719 and phosphatidylinositol 3′-kinase–mediated signal pathway in constitutive activation and oncogenic potential of c- kit receptor tyrosine kinase with the Asp814Val mutation

Critical roles of c-Kit tyrosine residues 567 and 719 in stem cell factor–induced chemotaxis: contribution of src family kinase and PI3-kinase on calcium mobilization and cell migration

Activating Mutation in the Catalytic Domain of c- kit Elicits Hematopoietic Transformation by Receptor Self-Association Not at the Ligand-Induced Dimerization Site

Growth-Supporting Activities of Fibronectin on Hematopoietic Stem/Progenitor Cells In Vitro and In Vivo: Structural Requirement for Fibronectin Activities of CS1 and Cell-Binding Domains

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only